Get startedLog in
    Picture of Iterum Therapeutics logo

    ITRMF — Iterum Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapValue Trap
    All News

    Brief: Iterum Therapeutics Reports Fourth Quarter Results

    Picture of Iterum Therapeutics logoIterum Therapeutics
    16/03/2023 11:26
    March 16 (Reuters) - Iterum Therapeutics PLC  ITRM.O :
    * ITERUM THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR
2022
FINANCIAL RESULTS
    * ITERUM THERAPEUTICS PLC - REGISTRATION TRIAL FOR UUTI
ONGOING
AND ON TRACK
    * ITERUM THERAPEUTICS PLC - CASH RUNWAY UNTIL MID-2024
    * ITERUM THERAPEUTICS PLC- QTRLY LOSS PER SHARE $0.41
    * ITERUM THERAPEUTICS PLC- QTRLY ADJUSTED LOSS PER SHARE
$0.52
    * ITERUM THERAPEUTICS PLC - CASH, CASH EQUIVALENTS AND
SHORT-TERM
INVESTMENTS WERE $60.8 MILLION AT DECEMBER 31, 2022

Source text for Eikon:  ID:nGNX6gtsX8 
Further company coverage:  ITRM.O

    Recent news on Iterum Therapeutics

    See all news